Tuesday Morning With Justin: Healthcare, Leadership & Life
Send us Fan Mail [https://www.buzzsprout.com/1949549/fan_mail/new] We unpack the shock of multi-million-dollar gene therapies and why a one-time cure can collide with a self-funded plan’s budget. We explain in vivo versus ex vivo approaches, where care happens, and how employers can think about coverage choices and preparation. • the cost reality of one-time gene therapies • who pays on a self-funded plan • tradeoffs of excluding versus covering therapies • why centers of excellence matter • differences between in vivo and ex vivo models • examples including hemophilia and sickle cell • operational needs for case management and stop-loss • a preview of hidden employer risks next week Music by Alex Lambert. Support the show [https://www.buzzsprout.com/1949549/support] Contact Justin via text 740-525-5259 or via email JFutrell@TrueNorthCompanies.com I welcome the opportunity to hear your feedback from this episode! Thanks again to my musically gifted friend Alex Lambert for the music. Also thanks to Kevin Asehan for the edits.
20 episoder
Kommentarer
0Vær den første til at kommentere
Tilmeld dig nu og bliv en del af Tuesday Morning With Justin: Healthcare, Leadership & Life-fællesskabet!